ENZ
Enzo Biochem, Inc.
Delisted
ENZ was delisted on the 17th of April, 2025.
47 hedge funds and large institutions have $34.7M invested in Enzo Biochem, Inc. in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 13 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
50% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 10
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
Holders
47
Holding in Top 10
1
Calls
$198K
Puts
$84K
Top Buyers
| 1 | +$624K | |
| 2 | +$245K | |
| 3 | +$69.8K | |
| 4 |
SMA
Sage Mountain Advisors
Atlanta,
Georgia
|
+$54.1K |
| 5 |
CC
Centiva Capital
New York
|
+$45.4K |
Top Sellers
| 1 | -$13.6M | |
| 2 | -$977K | |
| 3 | -$589K | |
| 4 |
RAM
Roumell Asset Management
Chevy Chase,
Maryland
|
-$518K |
| 5 |
Morgan Stanley
New York
|
-$239K |